Cocaine abuse and sensitization of striatal dopamine transmission: A critical review of the preclinical and clinical imaging literature
Abstract
Much effort has been devoted in the preclinical addiction literature to understanding the phenomenon of sensitization, an enhanced dopaminergic response in the nucleus accumbens that occurs after repeated exposure to psychostimulant drugs. Although sensitization has been reported in preclinical studies, studies of sensitization in humans measuring behavioral and physiological responses have been mixed and inconclusive. However, imaging studies with positron emission tomography (PET) and single photon emission computed tomography (SPECT) using a stimulant challenge to induce dopamine (DA) release provide a unique opportunity to probe DA transmission in cocaine dependent human subjects. In contrast to the basic science literature that predicted sensitization, three independent cohorts have shown a blunted DA response, or the opposite of sensitization, in human cocaine dependent subjects. This article reviews the methodological differences between the preclinical and clinical PET studies that have investigated DA sensitization in order to address the discrepancy between the human and animal literature. Synapse 62:851–869, 2008.Keywords
This publication has 173 references indexed in Scilit:
- Positron Emission Tomography of Monoaminergic Vesicular Binding in Aging and Parkinson DiseaseJournal of Cerebral Blood Flow & Metabolism, 2006
- Cocaine Dependence and D2 Receptor Availability in the Functional Subdivisions of the Striatum: Relationship with Cocaine-Seeking BehaviorNeuropsychopharmacology, 2004
- Loss of Striatal Vesicular Monoamine Transporter Protein (VMAT2) in Human Cocaine UsersAmerican Journal of Psychiatry, 2003
- Comparison of Cocaine‐ and Methamphetamine‐Evoked Dopamine and Glutamate Overflow in Somatodendritic and Terminal Field Regions of the Rat Brain during Acute, Chronic, and Early Withdrawal ConditionsAnnals of the New York Academy of Sciences, 2001
- A consideration of the dopamine D2 receptor monomer-dimer equilibrium and the anomalous binding properties of the dopamine D2 receptor ligand, N-methyl spiperoneJournal of Neural Transmission, 2001
- (−)-N-[11C]propyl-norapomorphine: a positron-labeled dopamine agonist for PET imaging of D2 receptorsNuclear Medicine and Biology, 2000
- Cocaine abusers do not show loss of dopamine transporters with ageLife Sciences, 1997
- Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transportersNuclear Medicine and Biology, 1996
- Amygdala dopamine levels are markedly elevated after self- but not passive-administration of cocaineBrain Research, 1994
- Reduced Clearance of Exogenous Dopamine in Rat Nucleus Accumbens, but Not in Dorsal Striatum, Following Cocaine Challenge in Rats Withdrawn from Repeated Cocaine AdministrationJournal of Neurochemistry, 1993